Navigation Links
Arena Pharmaceuticals Files European Marketing Authorization Application for Lorcaserin for Weight Control
Date:3/2/2012

Drug User Fee Act (PDUFA) target date of June 27, 2012. Eisai Inc. has exclusive rights to market and distribute lorcaserin in the United States subject to FDA approval of the lorcaserin NDA. Arena currently owns rights to lorcaserin outside of the United States.

About Arena Pharmaceuticals
Arena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs that target G protein-coupled receptors, an important class of validated drug targets, in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.

Arena Pharmaceuticals® and Arena® are registered service marks of the company.

Forward-Looking Statements
Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about the advancement, therapeutic indication and use, safety, efficacy, mechanism of action, and potential of lorcaserin; the regulatory review of the lorcaserin MAA submission and NDA resubmission, including the EMA's acceptance and review of the MAA and the timing for the FDA to complete its review of the NDA resubmission; working with the EMA and the Rapporteur and Co-rapporteur; the potential approval and commercialization of lorcaserin; the Eisai collaboration and potential activities thereunder; need for new treatments to manage weight; lorcaserin's patent coverage; and Arena's focus, goals, strategy, research and development programs, and ability to develop compounds and commercialize drugs. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, the following: Arena's MAA submission for r
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
2. Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia
3. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
4. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
5. Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
6. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
7. Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies
8. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
9. Critical Pharmaceuticals Enter Sustained Release hGH Arena
10. Arena Pharmaceuticals Announces Preliminary Results of Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
11. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... 26, 2015 Boston Scientific Corporation (NYSE: BSX ... th Annual Global Healthcare Conference on June 9 in ... Dan Brennan , executive vice president and chief financial ... will participate in a 35-minute question and answer session regarding ... a.m. PT. A live webcast of the presentation ...
(Date:5/26/2015)... 26, 2015 Xencor, Inc. (NASDAQ: XNCR ... for the treatment of autoimmune diseases, asthma and allergic ... , President and Chief Executive Officer, will present at ... 2015 at 8:30 a.m. ET in New ... webcast of the presentation will be available on the ...
(Date:5/26/2015)... May 26, 2015  Northstar Global Business Services, ... solidified a deal with Mr. Checkout, a national ... anti-snoring product, SNORenz to brick and mortar retail ... a cross section of about fifty convenience stores, ... providing valuable statistics during the lead time the ...
Breaking Medicine Technology:Boston Scientific To Participate In The Goldman Sachs 36th Annual Global Healthcare Conference 2Xencor to Present at Jefferies 2015 Healthcare Conference 2Northstar announces in-store rollout deal with national distribution group reaching more than 35,000 stores nationwide 2Northstar announces in-store rollout deal with national distribution group reaching more than 35,000 stores nationwide 3
... for clinical testing in human ... cancer ... issue, Cancer,Research published a peer-reviewed article from Genelux Corporation,describing successful eradication ... virus developed by Genelux scientists.,These promising results make a compelling case ...
... program to provide school-based support, and feminine hygiene products to girls in ... ... YORK, Nov. 12 Girls living in sub-Saharan,Africa can miss up to ... sanitary protection and other resources to manage their,periods. To help give girls ...
Cached Medicine Technology:Tumor Eradication Article Published by Cancer Research 2Tumor Eradication Article Published by Cancer Research 3Tampax and Always Launch Protecting Futures Program Dedicated to Helping African Girls Stay in School 2Tampax and Always Launch Protecting Futures Program Dedicated to Helping African Girls Stay in School 3Tampax and Always Launch Protecting Futures Program Dedicated to Helping African Girls Stay in School 4Tampax and Always Launch Protecting Futures Program Dedicated to Helping African Girls Stay in School 5
(Date:5/26/2015)... (PRWEB) May 26, 2015 Irwin Gross, ... and directed a hospital-wide Patient Blood Management (PBM) initiative ... reduced overall blood usage by more than 60 percent ... , Covered in detail in an article in the ... in substantially reduced perioperative red cell loss, less acute ...
(Date:5/26/2015)... Two addiction experts from Anaheim ... on a CNBC radio podcast for a “state ... KCAA AM 1050, the podcast features Tim Salyer, Anaheim ... as they discuss current statistics on drug and alcohol ... million Americans. The program, titled “Addiction, Self-Hatred, Hope and ...
(Date:5/26/2015)... 26, 2015 Synthetic cannabinoids attempt ... an article published by International Business Times ... K2, Spice, and black mamba) causes unpredictable medical ... synthetic substances make it nearly impossible for medical ... of the substance due to the frequency in ...
(Date:5/26/2015)... New Brunswick (PRWEB) May 26, 2015 ... announce the successful upgrade of the DMi Partners ... This version was the first in Indosoft's contact center ... API improvements, added screen support for such trunk features ... screens, improved lead management, and included upgrades to ...
(Date:5/26/2015)... CA (PRWEB) May 26, 2015 i2i ... Analytics solutions for more than 15 years, has earned ... National Committee for Quality Assurance (NCQA) for its flagship ... “We are proud of the work we have done ... are grateful for the acknowledgement from NCQA once again,” ...
Breaking Medicine News(10 mins):Health News:Published Study: Patient Blood Management (PBM) Program Slashes Blood Use, Transfusions and Costs while Resulting in Better Patient Outcomes 2Health News:Published Study: Patient Blood Management (PBM) Program Slashes Blood Use, Transfusions and Costs while Resulting in Better Patient Outcomes 3Health News:Anaheim Lighthouse Staff Joined Dr. Marissa Pei’s in a Conversation on Drug and Alcohol Addiction 2Health News:Anaheim Lighthouse Staff Joined Dr. Marissa Pei’s in a Conversation on Drug and Alcohol Addiction 3Health News:Synthetic Cannabinoids Can Cause Psychotic Episodes; Doctors at a Loss for Treatment 2Health News:Synthetic Cannabinoids Can Cause Psychotic Episodes; Doctors at a Loss for Treatment 3Health News:DMi Partners Upgrades to Indosoft Q-Suite 5.8 2Health News:DMi Partners Upgrades to Indosoft Q-Suite 5.8 3Health News:i2iTracks Earns NCQA 2014 PCMH Prevalidation 2Health News:i2iTracks Earns NCQA 2014 PCMH Prevalidation 3
... visually impaired, navigating city streets or neighborhoods has constant challenges. ... rudimentary technologya simple caneto help them make their way through ... California engineering researchers is working to change that by developing ... design first shown a year ago is now being further ...
... Steven Reinberg HealthDay Reporter , WEDNESDAY, May ... prescribed drugs, the antidepressant Paxil and the cholesterol-lowering medication ... new study finds. The increase is most apparent ... is already too high, the researchers noted. "This ...
... 2011) The Maryland Stem Cell Research Commission (Commission) ... in response to its three FY 2011 Requests for ... Technology Development Corporation (TEDCO) approved the Commission,s recommendation to ... Research Fund,s (MSCRF) $10.4 million FY 2011 budget. ...
... May 25 (HealthDay News) -- The Internet has put the ... also allowed banned or controlled substances to slip within their ... online May 19 in Drug Testing and Analysis , ... contain ingredients other than those claimed and can be hazardous. ...
... obese women with less-than-optimal levels of vitamin D who lose ... increases in circulating levels of this fat-soluble nutrient, according to ... Center. , "Since vitamin D is generally lower in persons ... account, in part, for the link between obesity and diseases ...
... known for years that playing violent video games causes ... a new University of Missouri (MU) study provide one ... video game players become less responsive to violence, and ... "Many researchers have believed that becoming desensitized to ...
Cached Medicine News:Health News:'Guide vests' -- robotic navigation aids for the visually impaired 2Health News:Combo of Paxil, Pravachol May Raise Blood Sugar 2Health News:Combo of Paxil, Pravachol May Raise Blood Sugar 3Health News:Maryland Stem Cell Research Commission funds 36 new projects in FY 2011 2Health News:Maryland Stem Cell Research Commission funds 36 new projects in FY 2011 3Health News:Illegal Drugs Easy to Buy on the Internet, U.K. Study Finds 2Health News:Losing more than 15 percent of body weight significantly boosts vitamin D levels in overweight women 2Health News:Losing more than 15 percent of body weight significantly boosts vitamin D levels in overweight women 3Health News:Violent video games reduce brain response to violence and increase aggressive behavior 2
... The VitalView™ Central Station is ... Criticare bedside monitors for vital signs ... displayed in real time, with simultaneous ... ECG events, graphical and tabular trends ...
... These specialty Eraser instruments have ... surgeon with the right tool for ... introduced a series of 25 gauge ... provide discrete treatment of target tissues ...
... Chart Manager provides powerful workflow tools such ... integrated transcription services, and customized flow sheets ... eliminates the need for paper charts. ... a paperless office now and can easily ...
... The Cerner PowerChart Electronic Medical ... solutions designed to create an enterprise-wide, ... (EMR). PowerChart streamlines the workflow process ... access to the functions that support ...
Medicine Products: